scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.510270425 |
P698 | PubMed publication ID | 9537449 |
P2093 | author name string | Rapp UR | |
Schwarz M | |||
Buchmann A | |||
Troppmair J | |||
Buenemann CL | |||
Kaestner K | |||
Kalkuhl A | |||
Stinchcombe S | |||
P2860 | cites work | Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1 | Q24617367 |
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Protein kinase C alpha activates RAF-1 by direct phosphorylation | Q28260100 | ||
Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors | Q28267177 | ||
The ins and outs of Raf kinases | Q28307284 | ||
Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling | Q29617453 | ||
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane | Q29618478 | ||
Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro | Q30452723 | ||
Striking homology of the ‘Variable’ N-terminal as well as the ‘conserved core’ domains of the mouse and human TATA-factors (TFIID) | Q33350959 | ||
Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity | Q33676544 | ||
14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 | ||
Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis | Q37389008 | ||
Oncogene activation in chemical carcinogenesis | Q39559546 | ||
Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors | Q40483537 | ||
Transcriptional regulation by extracellular signals: mechanisms and specificity | Q40579098 | ||
Activators and effectors of ras p21 proteins | Q40757563 | ||
MAP kinase kinase kinase, MAP kinase kinase and MAP kinase | Q40757575 | ||
Role of receptors in human and rodent hepatocarcinogenesis | Q40933381 | ||
Ras effectors | Q41099716 | ||
Phosphorylation of Raf by ceramide-activated protein kinase | Q41270560 | ||
Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mouse | Q42196397 | ||
Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor | Q42796135 | ||
Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera | Q44670247 | ||
14-3-3 and its possible role in co-ordinating multiple signalling pathways | Q47986680 | ||
14-3-3 protein homologs required for the DNA damage checkpoint in fission yeast | Q48080836 | ||
Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. | Q53456254 | ||
Absence of mutations in the functional parts of the p120-GAP gene in carcinogen-induced mouse liver tumors | Q53487035 | ||
Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H/He mice | Q53494621 | ||
Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors. | Q54213666 | ||
Sequence preference of 7,12-dimethylbenz[a]anthracene-syn-diol epoxide-DNA binding in the mouse H-ras gene detected by UvrABC nucleases. | Q54584942 | ||
Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts | Q59095246 | ||
Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells | Q71118388 | ||
Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver | Q72331241 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1081-1088 | |
P577 | publication date | 1998-04-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions | |
P478 | volume | 27 |
Q33864770 | Ah receptor ligands and tumor promotion: survival of neoplastic cells |
Q45183645 | B-raf and Ha-ras mutations in chemically induced mouse liver tumors |
Q22011109 | Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1 |
Q33916701 | Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate |
Q45408799 | Raf-1 and protein kinase B regulate cell survival through the activation of NF-kappaB in hepatitis B virus X-expressing cells |
Q33964689 | Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells |
Q34348449 | Searching new targets for anticancer drug design: the families of Ras and Rho GTPases and their effectors |
Q42506244 | Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. |
Q36972045 | Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only |
Search more.